1,125
Participants
Start Date
March 31, 2014
Primary Completion Date
December 31, 2026
Study Completion Date
June 30, 2027
Enzalutamide
NSAA
LHRHA or Surgical Castration
St Vincent's Hospital Sydney, Darlinghurst
Prince of Wales Hospital, Randwick
Chris O'Brien Lifehouse, Camperdown
Genesis Care North Shore, St Leonards
Sydney Adventist Hospital, Wahroonga
Concord Cancer Centre - Concord Repatriation General Hospital, Concord
St. George Hospital, Kogarah
Tamworth Rural Referral Hospital, Tamworth
Port Macquarie Base Hospital, Port Macquarie
Coffs Harbour Health Campus, Coffs Harbour
The Tweed Hospital, Tweed Heads
Wollongong Hospital, Wollongong
Riverina Cancer Care Centre, Wagga Wagga
Nepean Cancer Care Centre, Kingswood
Central West Cancer Services, Orange
Peter MacCallum Cancer Centre - East Melbourne, East Melbourne
St. Vincents Hospital Melbourne, Fitzroy
Austin Hospital, Heidelberg
Australian Urology Associates, Malvern
Monash Cancer Centre Moorabbin, Bentleigh East
Peninsula South Eastern Haematology & Oncology Group- Peninsula Oncology Centre, Frankston
Waikato Hospital, Hamilton
University Hospital Geelong, Geelong
Goulburn Valley Health, Shepparton
Border Medical Oncology, Wodonga
Royal Brisbane and Women's Hospital, Herston
Princess Alexandra Hospital, Woolloongabba
Gold Coast University Hospital, Southport
Sunshine Coast University Hospital, Birtinya
Townsville Hospital, Douglas
Royal Adelaide Hospital, Adelaide
Adelaide Cancer Centre - Ashford Cancer Care Centre, Kurralta Park
Flinders Medical Centre, Bedford Park
Fiona Stanley Hospital (formerly Royal Perth Hospital), Perth
Sir Charles Gairdner Hospital, Nedlands
Royal Hobart Hospital, Hobart
Christchurch Hospital, Christchurch
Dana Farber Cancer Institute, Boston
Royal Darwin Hospital, Tiwi
Bendigo Hospital, Bendigo
Eastern Health Box Hill Hospital, Melbourne
CancerCare Manitoba, Winnipeg
Galway University Hospital, Galway
University Hospital Waterford, Waterford
Auckland City Hospital, Auckland
Prostate Cancer Institute - Southern Alberta Institute of Urology, Calgary
Cross Cancer Institute, Edmonton
BCCA - Fraser Valley Cancer Center, Surrey
BCCA Vancouver Centre, Vancouver
Horizon Health Network - Dr Everett Chalmers Hospital, Fredericton
Saint John Regional Hospital, Saint John
QEII Health Sciences Centre, Capital District Health Authority, Halifax
Cambridge Memorial Hospital, Cambridge
Juravinski Cancer Centre, Hamilton
Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston
London Regional Cancer Program, London
Lakeridge Health Oshawa, Oshawa
Ottawa Hospital Cancer Centre, Ottawa
Algoma District Cancer Program Sault Area Hospital, Sault Ste. Marie
Thunder Bay Regional Health Sciences Centre, Thunder Bay
University Health Network - Princess Margaret Hospital, Toronto
Hôpital Notre-Dame, Montreal
CHUQ-Pavillon Hotel-Dieu de Quebec, Québec
Allan Blair Cancer Centre, Regina
Saskatoon Cancer Centre, Saskatoon
Beaumont Hospital, Beaumont
Beacon Private Hospital, Dublin
St Vincent's University Hospital, Dublin
Mater Misercordiae University Hospital, Dublin
Mater Private Hospital, Dublin
St James Hospital, Dublin
Adelaide and Meath Hospital - National Children's Hospital, Tallaght
Royal Cornwall Hospital, Truro
Royal Sussex Hospital, Brighton
Kent and Canterbury Hospital, Canterbury
Aberdeen Royal Infirmary, Aberdeen
Velindre Cancer Centre, Cardiff
University College Hospital London, London
Guys and St Thomas Hospital, London
Royal Marsden Hospital, London
University Hospital Southampton, Southampton
Great Western Hospital, Swindon
Collaborators (1)
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
OTHER
Cancer Trials Ireland
NETWORK
Canadian Cancer Trials Group
NETWORK
Astellas Pharma Inc
INDUSTRY
University of Sydney
OTHER